One-pot synthesis and molecular docking study of pyrazoline derivatives as an anticancer agent

Pyrazoline derivatives as an anticancer agent

Authors

  • Tengku Anggia Fitri Faculty of Mathematics and Natural Sciences, Universitas Riau, Riau, Indonesia
  • Rudi Hendra Faculty of Mathematics and Natural Sciences, Universitas Riau, Riau, Indonesia https://orcid.org/0000-0002-1103-8261
  • Adel Zamri Faculty of Mathematics and Natural Sciences, Universitas Riau, Riau, Indonesia https://orcid.org/0000-0003-4066-877X

DOI:

https://doi.org/10.46542/pe.2023.232.260265

Keywords:

Anticancer, Molecular docking, One-pot synthesis, Pyrazoline

Abstract

Background: Pyrazoline is a series of heterocyclics with an  N–N bond linkage, which is the determining factor in their biological activities, including anticancer.    

Objectives: This research aims to synthesise pyrazoline derivative compounds with anticancer potential.    

Method: 4-Metoxyacetophenon, halogen-substituted benzaldehyde, and phenylhydrazine were used to prepare pyrazoline derivatives (4a, b) under basic conditions using a microwave-assisted, one-pot, three-component reaction method. UV, FTIR, 1H-NMR, and HRMS spectrometers were used to confirm the molecular structure of pyrazolines (4a, b) using their UV, FTIR, 1H-NMR, and HRMS spectra. The anticancer activity of the compounds (4a, b) was evaluated using molecular docking studies to observe the receptor-ligand interaction of the compounds with the Estrogen Receptor Erα.    

Result: The pyrazoline (4a, b) produced positive results, with approximately 40% yield. It can be used as an anticancer agent due to its binding free energy values of -9.74 and -9.29 respectively, and a receptor-ligan interaction.   

Discussion and Conclusion: New pyrazolines (4a, b) have been successfully synthesised with good yields through the one-pot three-component reaction and have potential as anti-breast cancer agents because of their good affinity for the ERα evidenced by the negative binding free energy values and receptor-ligand interactions that are similar to natural ligand, 4OHT.

Author Biographies

Tengku Anggia Fitri, Faculty of Mathematics and Natural Sciences, Universitas Riau, Riau, Indonesia

Department of Chemistry

Rudi Hendra, Faculty of Mathematics and Natural Sciences, Universitas Riau, Riau, Indonesia

Department of Chemistry

Adel Zamri, Faculty of Mathematics and Natural Sciences, Universitas Riau, Riau, Indonesia

Department of Chemistry

References

Ahmad, A., Husain, A., Khan, S. A., Mujeeb, M. & Bhandari, A. 2016. Synthesis, Antimicrobial and Antitubercular Activities of Some Novel Pyrazoline Derivatives Antimicrobial and Antitubercular Activities of Novel Pyrazoline Derivatives. Journal of Saudi Chemical Society, 20(5):577–84 https://doi.org/10.1016/j.jscs.2014.12.004

Ali, S., Rasool, M., Chaoudhry, H., Pushparaj, P. N., Jha, P., Hafiz, A., Mahfooz, M., Sami, G.A., Kamal, M.A., Bashir, S., Ali, A. & Jamal, M.S. (2016). Molecular Mechanisms and Mode of Tamoxifen Resistance in Breast Cancer. Bioinformation, 12(3):135-139 https://doi.org/10.6026/97320630012135

Constantinescu, T. & Claudiu N.L. (2021). Anticancer Activity of Natural and Synthetic Chalcones. International Journal of Molecular Sciences, 22(21) https://doi.org/10.3390/ijms222111306

Hawaiz, F.E., Hussein, A.J. & Samad, M.K. (2014). One-Pot Three Component Synthesis of Some New Azo-Pyrazoline Derivatives. European Journal of Chemistry. 5(2): 233–236 https://doi.org/10.5155/eurjchem.5.2.233-236.979

Kumar, L., Lal, K., Yadav, P., Kumar, A., & Paul, A.K. (2020). Synthesis, Characterization, α-Glucosidase Inhibition and Molecular Modeling Studies of Some Pyrazoline-1H-1,2,3-Triazole Hybrids. Journal of Molecular Structure, 1216 https://doi.org/10.1016/j.molstruc.2020.128253

Lumachi, F. (2015). Current Medical Treatment of Estrogen Receptor-Positive Breast Cancer. World Journal of Biological Chemistry, 6(3):231 http://dx.doi.org/10.4331/wjbc.v6.i3.231

Sharma, S., Kaur, S., Bansal, T. & Gaba, J. (2014). Review on Synthesis of Bioactive Pyrazoline Derivatives. Chemical Science Transactions, 3(3):861-875. https://doi.org/10.7598/cst2014.796

Sakthinathan, S.P., Vanangamudi, G. & Thirunarayanan, G. (2012). Synthesis, Spectral Studies and Antimicrobial Activities of Some 2-Naphthyl Pyrazoline Derivatives. Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 95:693–700 https://doi.org/10.1016/j.saa.2012.04.082

Sun, Y.S., Zhao, Z., Yang, Z.N., Xu, F., Lu, H.J., Zhu, Z.Y., Shi, W., Jiang, J., Yao, P.P. & Zhu, H. P. (2017). Risk Factors and Preventions of Breast Cancer. International Journal of Biological Sciences, 13(11):1387–97. https://doi.org/10.7150/ijbs.21635

Zamri, A., Teruna, H.Y. & Ikhtiarudin, I. (2016). The Influence of Power Variation on Selectivity of Synthesis Reaction of 2 ’-hydroxychalcone Analogue Under Microwave Irradiation. Molekul, 11:299–307 http://dx.doi.org/10.20884/1.jm.2016.11.2.220

Downloads

Published

09-06-2023

How to Cite

Fitri, T. A., Hendra, R., & Zamri, A. (2023). One-pot synthesis and molecular docking study of pyrazoline derivatives as an anticancer agent: Pyrazoline derivatives as an anticancer agent. Pharmacy Education, 23(2), p. 260–265. https://doi.org/10.46542/pe.2023.232.260265

Issue

Section

Special Edition